Neuroscience

Targeted panel testing superior for neuromuscular diseases

(HealthDay)—Targeted panel testing has the highest clinical yield for molecular diagnosis of neuromuscular diseases (NMDs), according to a study published in the February issue of the Annals of Neurology.

Oncology & Cancer

New colorectal cancer risk factor identified

Adiponectin, a collagen-like protein secreted by fat cells, derives from the ADIPOQ gene. Variations in this gene may increase risk for type 2 diabetes, cardiovascular disease, and various cancers. A new study that links ...

Genetics

Many US doctors wary of genetic testing

(HealthDay)—Many American doctors may not support genetic testing in patients without a major family history of certain illnesses, suggests a new survey of physicians. The report appears in the Nov. 13 issue of the New ...

Oncology & Cancer

Genetic testing could improve breast cancer prevention

Scientists used mathematical models to show that analysing genetic data, alongside a range of other risk factors, could substantially improve the ability to flag up women at highest risk of developing breast cancer.

Medical research

Rapid test to diagnose severe sepsis

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

page 20 from 35